Matthew Meyerson, M.D. Ph.D.
Affiliations: | Medical Oncology | Dana-Farber Cancer Institute, Boston, MA, United States |
Area:
oncology, genomicsGoogle:
"Matthew Meyerson"Mean distance: 15.99 (cluster 51) | S | N | B | C | P |
Children
Sign in to add trainee| Ananthan Sadagopan | research assistant | (ID Tree) | |
| Stephen Tang | research assistant | 2018-2019 | Harvard (GenetiTree) |
| Hersh V Gupta | research assistant | 2020-2022 | (Chemistry Tree) |
| Adam Bass | grad student | Dana-Farber Cancer Institute | |
| Mohamed Abazeed | post-doc | Harvard Medical School | |
| Ami S. Bhatt | post-doc | (Chemistry Tree) | |
| William Gibson | post-doc | ||
| Trevor Pugh | post-doc | Dana-Farber Cancer Institute (Evolution Tree) | |
| Srinivas R. Viswanathan | post-doc | (Chemistry Tree) | |
| Rameen Beroukhim | post-doc | 2005-2009 | Dana-Farber Cancer Institute |
| Amit Dutt | post-doc | 2005-2010 | Dana Farber Cancer Institute |
| Wendy M. Winckler | research scientist | 2005-2009 | Dana Farber Cancer Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tarantino P, Gupta H, Hughes ME, et al. (2023) Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature Communications. 14: 8321 |
| Tan KT, Slevin MK, Leibowitz ML, et al. (2023) Neotelomeres and Telomere-Spanning Chromosomal Arm Fusions in Cancer Genomes Revealed by Long-Read Sequencing. Biorxiv : the Preprint Server For Biology |
| Pulice JL, Meyerson M. (2023) Dosage amplification dictates oncogenic regulation by the lineage factor in lung adenocarcinoma. Biorxiv : the Preprint Server For Biology |
| Gibson WJ, Sadagopan A, Shoba VM, et al. (2023) Bifunctional Small Molecules That Induce Nuclear Localization and Targeted Transcriptional Regulation. Journal of the American Chemical Society |
| Tarantino P, Gupta H, Hughes ME, et al. (2023) Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer. Nature Communications. 14: 7496 |
| Groves A, Ward A, Li YY, et al. (2023) Loss of heterozygosity does not occur in BRCA1/2 mutant pediatric solid and central nervous system tumors. Pediatric Blood & Cancer. e30643 |
| Singh H, Keller RB, Kapner KS, et al. (2023) Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Gibson WJ, Sadagopan A, Shoba VM, et al. (2023) Bifunctional small molecules that induce nuclear localization and targeted transcriptional regulation. Biorxiv : the Preprint Server For Biology |
| Shih J, Sarmashghi S, Zhakula-Kostadinova N, et al. (2023) Cancer aneuploidies are shaped primarily by effects on tumour fitness. Nature |
| Alessi JV, Wang X, Elkrief A, et al. (2023) Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer |